Presentation
30 May 2023 Dy3+-doped phosphate glass optical fibers for 577 nm wavelength fiber lasers (Conference Presentation)
Author Affiliations +
Abstract
Lasers emitting in the visible find applications in biology and medicine. Considering the success of near-infrared fiber lasers, the possibility to optically pump rare-earth-doped fibers in the blue to directly obtain visible emission is attractive. The recent progress in the field of GaN-based blue laser diodes offers new scopes. Dy3+-doped materials have received much interest because of their intense yellow emission originating from the 4F9/2→6H13/2 transition. An involvement of a glass matrix benefiting from enhanced thermo-mechanical properties would ease diode pumping. We report on the synthesis of a series of novel phosphate glasses in the system P2O5-Al2O3–BaO-K2O doped with Dy2O3. The Dy3+ concentrations were 0.05, 0.21, 0.83 and 2.5 [1020 ions/cm3]. The glasses were synthesized by the standard melt-quenching technique and thoroughly characterized in their physical, thermo-mechanical and optical properties. A Dy3+-doped optical fiber was drawn by preform drawing from the developed glasses, with the preform being obtained by rod-in tube technique, combining a cast core and an extruded cladding. Preliminary emission results in the visible from the fabricated fiber will be reported.
Conference Presentation
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Diego Pugliese, Martha Segura, Nadia Giovanna Boetti, Joris Lousteau, Guido Perrone, Davide Janner, Sami Slimi, Pavel A. Loiko, Mailyn Ceballos, and Xavier Mateos "Dy3+-doped phosphate glass optical fibers for 577 nm wavelength fiber lasers (Conference Presentation)", Proc. SPIE 12573, Specialty Optical Fibres, 125730A (30 May 2023); https://doi.org/10.1117/12.2665269
Advertisement
Advertisement
KEYWORDS
Glasses

Fiber lasers

Optical fibers

Phosphates

Lasers

Diodes

Second-harmonic generation

RELATED CONTENT


Back to Top